-
公开(公告)号:US5621109A
公开(公告)日:1997-04-15
申请号:US455922
申请日:1995-05-31
Applicant: Daniel W. Norbeck , Hing L. Sham , Dale J. Kempf , Chen Zhao
Inventor: Daniel W. Norbeck , Hing L. Sham , Dale J. Kempf , Chen Zhao
IPC: A61K31/42 , A61K31/425 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61P35/00 , A61P43/00 , C07C281/02 , C07C281/06 , C07D213/30 , C07D213/38 , C07D213/40 , C07D261/08 , C07D263/32 , C07D265/30 , C07D275/02 , C07D277/24 , C07D277/28 , C07D307/52 , C07D309/04 , C07D405/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D263/34 , C07D277/54
CPC classification number: C07D213/30 , C07C281/02 , C07C281/06 , C07D213/38 , C07D213/40 , C07D261/08 , C07D263/32 , C07D265/30 , C07D275/02 , C07D277/24 , C07D277/28 , C07D307/52 , C07D309/04 , C07D405/12 , C07D413/12 , C07D417/12 , C07C2101/14
Abstract: A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed wherein the terms R.sub.1, R.sub.2, R.sub.5, R.sub.6, Y, Y', m and n are herein defined.
Abstract translation: 公开了下式的逆转录病毒蛋白酶抑制化合物:其中本文定义术语R1,R2,R5,R6,Y,Y',m和n。
-
公开(公告)号:US5554783A
公开(公告)日:1996-09-10
申请号:US418978
申请日:1995-04-07
Applicant: Dale J. Kempf , Daniel W. Norbeck , Lynn M. Codacovi
Inventor: Dale J. Kempf , Daniel W. Norbeck , Lynn M. Codacovi
IPC: A61B5/00 , A61B5/15 , A61K38/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/59 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/42 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/70 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07D521/00 , C07K5/06 , C07K5/065 , G01N33/487 , C07C271/10
CPC classification number: C07C45/74 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C33/46 , C07C381/00 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/59 , C07C45/62 , C07C45/673 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/42 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/70 , C07D213/75 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07K5/06026 , C07K5/06078 , A61K38/00
Abstract: A retroviral protease inhibiting compound of the formula A--X--B is disclosed. Also disclosed are a composition and method for inhibiting a retroviral protease and for treating an HIV infection. Also disclosed are processes and intermediates useful for the preparation of the retroviral protease inhibitors.
Abstract translation: 公开了式A-X-B的逆转录病毒蛋白酶抑制化合物。 还公开了抑制逆转录病毒蛋白酶和治疗HIV感染的组合物和方法。 还公开了可用于制备逆转录病毒蛋白酶抑制剂的方法和中间体。
-
公开(公告)号:US5541206A
公开(公告)日:1996-07-30
申请号:US423387
申请日:1995-04-25
Applicant: Dale J. Kempf , Daniel W. Norbeck , Hing Leung Sham , Chen Zhao
Inventor: Dale J. Kempf , Daniel W. Norbeck , Hing Leung Sham , Chen Zhao
IPC: A61K31/425 , A61K31/427 , A61K38/00 , A61K45/06 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/59 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07D521/00 , C07K5/06 , C07K5/065
CPC classification number: C07D207/08 , A61K31/425 , A61K31/427 , A61K45/06 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C33/46 , C07C381/00 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/59 , C07C45/62 , C07C45/673 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07K5/06026 , C07K5/06078 , A61K38/00
Abstract: A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
-
公开(公告)号:US5539122A
公开(公告)日:1996-07-23
申请号:US410996
申请日:1995-03-27
Applicant: Dale J. Kempf , Daniel W. Norbeck , Hing L. Sham
Inventor: Dale J. Kempf , Daniel W. Norbeck , Hing L. Sham
IPC: A61K31/425 , A61K31/427 , A61K38/00 , A61K45/06 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/59 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07D521/00 , C07K5/06 , C07K5/065
CPC classification number: C07D207/08 , A61K31/425 , A61K31/427 , A61K45/06 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C33/46 , C07C381/00 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/59 , C07C45/62 , C07C45/673 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D231/12 , C07D233/56 , C07D233/64 , C07D233/84 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D249/08 , C07D261/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D417/12 , C07K5/06026 , C07K5/06078 , A61K38/00
Abstract: A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
-
公开(公告)号:US5151438A
公开(公告)日:1992-09-29
申请号:US675780
申请日:1991-03-27
Applicant: Hing L. Sham , Daniel W. Norbeck , Dale J. Kempf , Chen Zhao
Inventor: Hing L. Sham , Daniel W. Norbeck , Dale J. Kempf , Chen Zhao
IPC: A61K38/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/59 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C217/48 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/16 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/30 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/70 , C07D213/81 , C07D213/82 , C07D215/16 , C07D217/16 , C07D217/26 , C07D233/84 , C07D239/38 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/36 , C07D277/42 , C07D277/56 , C07D295/088 , C07D295/15 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D303/04 , C07D303/22 , C07D303/36 , C07D303/48 , C07D417/12 , C07D487/04 , C07D521/00 , C07F9/32 , C07F9/53 , C07K5/02 , C07K5/06
CPC classification number: C07D213/30 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C217/48 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/16 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C33/46 , C07C381/00 , C07C43/164 , C07C43/1742 , C07C43/2055 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/004 , C07C45/29 , C07C45/567 , C07C45/59 , C07C45/62 , C07C45/673 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07D207/08 , C07D207/24 , C07D209/42 , C07D211/62 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/70 , C07D213/81 , C07D213/82 , C07D215/16 , C07D217/16 , C07D217/26 , C07D231/12 , C07D233/56 , C07D233/84 , C07D239/38 , C07D249/08 , C07D263/32 , C07D277/24 , C07D277/28 , C07D277/36 , C07D277/42 , C07D277/56 , C07D295/088 , C07D295/15 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D303/04 , C07D303/22 , C07D303/36 , C07D303/48 , C07D417/12 , C07D487/04 , C07F9/3241 , C07F9/5333 , C07K5/021 , C07K5/06043 , C07K5/06052 , C07K5/06191 , A61K38/00
Abstract: Compounds are disclosed which are retroviral protease inhibitors. Also disclosed are methods of using the compounds and compositions for inhibiting a retroviral protease and for treating an HIV infection.
Abstract translation: 公开了作为逆转录病毒蛋白酶抑制剂的化合物。 还公开了使用化合物和组合物抑制逆转录病毒蛋白酶和治疗HIV感染的方法。
-
公开(公告)号:US5091575A
公开(公告)日:1992-02-25
申请号:US713644
申请日:1991-06-10
Applicant: Jay R. Luly , Jacob J. Plattner , Dale J. Kempf
Inventor: Jay R. Luly , Jacob J. Plattner , Dale J. Kempf
CPC classification number: C07K5/0227 , C07K5/06043 , C07K5/06078 , C07K5/06139 , A61K38/00
Abstract: A renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is C.dbd.O or CHOH; U is CH.sub.2 or NR.sup.2, provided that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, .alpha.,.alpha.-dimethylbenzyl, 1-benzyloxyethyl; phenethyl, phenoxy, thiophenoxy or anilino; R.sub.2 is hydrogen or loweralkyl; R.sub.3 is loweralkyl, [(alkoxy)alkoxy]alkyl, (thioalkoxy)alkyl; lowerakenyl, benzyl or heterocyclic ring substituted methyl; R.sub.4 is loweralkyl, cycloalkylmethyl or benzyl; R.sub.5 is vinyl, formyl, hydroxymethyl or hydrogen; R.sub.7 is hydrogen or loweralkyl; R.sub.8 and R.sub.9 are independently selected from OH and NH.sub.2 ; and R.sub.6 is hydrogen, loweralkyl, vinyl or arylalkyl; provided that when R.sub.5 and R.sub.7 are both hydrogen and R.sub.8 and R.sub.9 are OH, the carbon bearing R.sub.5 is of the "R" configuration and the carbon bearing R.sub.6 is of the "S" configuration; or pharmaceutically acceptable salts or esters thereof. Also disclosed are renin inhibiting compositions, a method of treating hypertension, methods of making the renin inhibiting compounds and intermediates useful in making the renin inhibiting compounds.
Abstract translation: 下式的肾素抑制化合物:其中A是取代基; W是C = O或CHOH; U是CH 2或NR 2,条件是当W是CHOH时,U是CH 2; R1是低级烷基,环烷基甲基,苄基,4-甲氧基苄基,卤代苄基,(1-萘基)甲基,(2-萘基)甲基,(4-咪唑基)甲基,α,α-二甲基苄基,1-苄氧基乙基; 苯乙基,苯氧基,硫代苯氧基或苯胺基; R2是氢或低级烷基; R3是低级烷基,[(烷氧基)烷氧基]烷基,(硫代烷氧基)烷基; 苄基或杂环取代的甲基; R4是低级烷基,环烷基甲基或苄基; R5是乙烯基,甲酰基,羟甲基或氢; R7是氢或低级烷基; R8和R9独立地选自OH和NH2; 和R6是氢,低级烷基,乙烯基或芳基烷基; 条件是当R 5和R 7均为氢且R 8和R 9为OH时,碳原子的R 5为“R”构型,碳原子的R 6为“S”构型; 或其药学上可接受的盐或酯。 还公开了肾素抑制组合物,治疗高血压的方法,制备肾素抑制化合物的方法和可用于制备肾素抑制化合物的中间体。
-
公开(公告)号:US5032577A
公开(公告)日:1991-07-16
申请号:US132356
申请日:1987-12-18
Applicant: Anthony K. L. Fung , Dale J. Kempf , Jay R. Luly , Saul H. Rosenberg , Jacob J. Plattner
Inventor: Anthony K. L. Fung , Dale J. Kempf , Jay R. Luly , Saul H. Rosenberg , Jacob J. Plattner
IPC: C12N9/99 , A61K31/165 , A61K31/44 , A61K31/4406 , A61K38/00 , A61P9/12 , C07C67/00 , C07C235/06 , C07C235/08 , C07C235/10 , C07C235/34 , C07C235/74 , C07C235/78 , C07C237/06 , C07C237/08 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/00 , C07C271/20 , C07C271/24 , C07C313/00 , C07C317/44 , C07C323/60 , C07C325/00 , C07C327/20 , C07C333/02 , C07D213/00 , C07D213/71 , C07D213/78 , C07D233/54 , C07K5/02 , C07K5/06 , C07K5/065 , C07K5/08 , C07K5/083 , C07K5/097 , C07K14/81
CPC classification number: C07D233/64 , C07K5/0202 , C07K5/0227 , C07K5/06026 , C07K5/06078 , C07K5/0802 , C07K5/0806 , C07K5/0808 , C07K5/0821 , C07K5/0823 , A61K38/00
Abstract: A renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; W is C.dbd.O or CHOH; U is CH.sub.2 or NR.sub.2, provided that when W is CHOH then U is CH.sub.2 ; R.sub.1 is loweralkyl, cycloalkylmethyl, benzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, (alpha,alpha)-dimethylbenzyl, 1-benzyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R.sub.2 is hydrogen or loweralkyl; R.sub.3 is loweralkenyl, [(alkoxy)alkoxy]alkyl, (thioalkoxy)alkyl, lowerakenyl, benzyl or heterocyclic ring substituted methyl; R.sub.4 is loweralkyl, cycloalkylmethyl or benzyl; R.sub.5 is vinyl, formyl, hydroxymethyl or hydrogen; R.sub.7 is hydrogen or loweralkyl; R.sub.8 and R.sub.9 are independently selected from OH and NH.sub.2 ; and R.sub.6 is hydrogen, loweralkyl, vinyl or arylalkyl; provided that when R.sub.5 and R.sub.7 are both hydrogen and R.sub.8 and R.sub.9 are OH, the carbon bearing R.sub.5 is of the "R" configuration and the carbon bearing R.sub.6 is of the "S" configuration, or pharmaceutically acceptable salts or esters thereof. Also disclosed are renin inhibiting compositions, a method of treating hypertension, methods of making the renin inhibiting compounds and intermediates useful in making the renin inhibiting compounds.
Abstract translation: 下式的肾素抑制化合物:其中A是取代基; W是C = O或CHOH; U是CH 2或NR 2,条件是当W是CHOH时,U是CH 2; (1-萘基)甲基,(2-萘基)甲基,(4-咪唑基)甲基,(α,α) - 二甲基苄基,1-苄氧基乙基,苯乙基,苯氧基 ,噻吩氧基或苯胺基; R2是氢或低级烷基; R3是低级烯基,[(烷氧基)烷氧基]烷基,(硫代烷氧基)烷基,低级,苄基或杂环取代的甲基; R4是低级烷基,环烷基甲基或苄基; R5是乙烯基,甲酰基,羟甲基或氢; R7是氢或低级烷基; R8和R9独立地选自OH和NH2; 和R6是氢,低级烷基,乙烯基或芳基烷基; 条件是当R 5和R 7均为氢且R 8和R 9为OH时,含碳的R 5为“R”构型,并且含碳的R 6为“S”构型,或其药学上可接受的盐或酯。 还公开了肾素抑制组合物,治疗高血压的方法,制备肾素抑制化合物的方法和可用于制备肾素抑制化合物的中间体。
-
公开(公告)号:US4994477A
公开(公告)日:1991-02-19
申请号:US173382
申请日:1988-03-24
Applicant: Dale J. Kempf , Saul H. Rosenberg , Jacob J. Plattner , Hing L. Shan , Biswanath De
Inventor: Dale J. Kempf , Saul H. Rosenberg , Jacob J. Plattner , Hing L. Shan , Biswanath De
IPC: A61K38/00 , C07D233/54 , C07D405/12 , C07D417/12 , C07K5/02 , C07K5/078
CPC classification number: C07D233/64 , C07D405/12 , C07D417/12 , C07K5/0207 , C07K5/06139 , A61K38/00
Abstract: A renin inhibiting compound of the formula: ##STR1## wherein A is a substituent; R.sub.1 is loweralkyl, loweralkenyl, alkoxyalkyl, [(alkoxy)alkoxy]alkyl, alkoxycarbonylalkyl, carboxyalkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; R.sub.2 is hydrogen, loweralkyl, cycloalkylmethyl or benzyl; D is a substituent; or pharmaceutically acceptable salts or esters thereof.Also disclosed are renin inhibiting compositions, a method of treating hypertension, methods of making the renin inhibiting compounds and intermediates useful in making the renin inhibiting compounds.
Abstract translation: 下式的肾素抑制化合物:其中A是取代基; R1是低级烷基,低级烯基,烷氧基烷基,[(烷氧基)烷氧基]烷基,烷氧基羰基烷基,羧基烷基,(硫代烷氧基)烷基,苄基或杂环取代的甲基; R2是氢,低级烷基,环烷基甲基或苄基; D是取代基; 或其药学上可接受的盐或酯。 还公开了肾素抑制组合物,治疗高血压的方法,制备肾素抑制化合物的方法和可用于制备肾素抑制化合物的中间体。
-
59.
公开(公告)号:US08524753B2
公开(公告)日:2013-09-03
申请号:US13362833
申请日:2012-01-31
Applicant: Dale J. Kempf , Charles A. Flentge , John T. Randolph , Peggy Huang , Larry L. Klein
Inventor: Dale J. Kempf , Charles A. Flentge , John T. Randolph , Peggy Huang , Larry L. Klein
IPC: A61K31/427 , A61K31/426 , C07D417/02 , C07D277/38
CPC classification number: C07D277/30 , A61K31/426 , A61K31/427 , A61K45/06 , C07C53/18 , C07D213/30 , C07D231/12 , C07D233/64 , C07D263/32 , C07D277/24 , C07D277/38 , C07D277/587 , C07D333/16 , C07D417/04
Abstract: Novel compounds of formula 1 or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
Abstract translation: 新的式1化合物或其药学上可接受的盐抑制细胞色素P450单加氧酶。
-
公开(公告)号:US08420596B2
公开(公告)日:2013-04-16
申请号:US12584716
申请日:2009-09-10
Applicant: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
Inventor: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik
IPC: A61K38/00
CPC classification number: C07K1/113 , C07D487/04
Abstract: The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Abstract translation: 本发明涉及新的大环化合物和在需要用所述大环化合物进行这种治疗的受试者中治疗丙型肝炎感染的方法。 本发明还涉及包含本发明化合物或其药学上可接受的盐,酯或前药与药学上可接受的载体或赋形剂组合的药物组合物。
-
-
-
-
-
-
-
-
-